Company Profile

Profile last edited on: 4/21/2023      CAGE: 875D1      UEI: H7EQKJLW3N11

Business Identifier: Improved availability and success of Medication-Assisted Treatment (MAT) for opioid use disorder (OUD),
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1660 Soldiers Field Road
Boston, MA 02135
   (617) 606-3113
Location: Single
Congr. District: 07
County: Suffolk

Public Profile

Q2i provides technology for healthcare teams treating Opioid Use Disorder (OUD) and Substance Use Disorder. Q2i's products, which include a healthcare team portal and patient mobile app, facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams. In addition, the firm's products incorporate market-leading artificial intelligence and machine learning that enable providers to predict risk of relapse and flag trending issues and areas of concern, resulting in more timely interventions and improved outcomes. Q2i's telehealth capabilities allow healthcare teams to care for OUD patients remotely, making treatment more accessible for OUD patients in remote areas.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Steven Paul Jenkins -- CEO

  Edwin D Boudreaux

  Aric Patel -- Clinical Research Coordinator at Q2i

  Thomas Scott -- Engineering Lead


  Dominic Trupiano -- Technical Product Owner

  Bengisu Tulu